Profile data is unavailable for this security.
About the company
Bal Pharma Limited is a fully integrated pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It is specialized in bulk actives, prescription drugs, generics and pharma intermediates. Its focused therapeutic areas are anti-diabetes, anti-histamine, anti-inflammatory, acne treatment, gastroenterology, cardiology, and dermatology. It offers a range of APIs, which includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment. Its finished formulation products cover dosage forms, such as tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments. The Company offers a range of natural medicine, which includes ANARSHA, ASHWAMED, AYURFINE, AYURFINE FORTE, AYURSULIN, IMMUWIN, LIPIVED, MENOLEAP CAPSULES, MENOLEAP SYRUP, PROLIFE, and BALPRO SYRUP.
- Revenue in INR (TTM)3.39bn
- Net income in INR73.92m
- Incorporated1987
- Employees--
- LocationBal Pharma LtdFour Mangoe LaneSurendra Mohan Ghosh SaraniBANGALORE 560052IndiaIND
- Phone+91 8 041379500
- Fax+91 8 022354057
- Websitehttps://www.balpharma.com/
Mergers & acquisitions
| Acquired company | BALPHARMA:NSI since announced | Transaction value |
|---|---|---|
| Golden Drugs Pvt Ltd | 18.40% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aarey Drugs and Pharmaceuticals Ltd | 3.48bn | 42.19m | 1.26bn | 0.00 | 27.01 | -- | 22.03 | 0.3618 | 1.66 | 1.66 | 137.72 | -- | -- | -- | -- | -- | -- | 2.78 | -- | 5.84 | 4.17 | 3.66 | 1.21 | 1.52 | -- | 1.63 | -- | -- | -14.96 | 3.70 | -42.38 | -9.40 | 10.95 | -- |
| Krebs Biochemicals And Industries Ltd | 504.22m | -197.29m | 1.33bn | 210.00 | -- | -- | -- | 2.65 | -9.16 | -9.16 | 23.41 | -55.29 | 0.2856 | 0.606 | 41.52 | -- | -11.17 | -17.87 | -16.29 | -27.01 | 86.94 | 24.50 | -39.13 | -58.62 | 0.1237 | -3.30 | 2.61 | -- | -3.29 | 1.09 | 20.10 | -- | 16.76 | -- |
| Vaishali Pharma Ltd | 862.80m | 7.19m | 1.49bn | -- | 297.33 | 3.35 | 121.52 | 1.73 | 0.45 | 0.45 | 77.83 | 39.97 | 1.09 | 43.39 | 1.67 | -- | 0.9051 | 3.21 | 1.53 | 7.50 | 13.75 | 16.14 | 0.8332 | 3.59 | 2.24 | 0.3624 | 0.2395 | -- | 23.85 | 2.82 | -89.11 | 0.1492 | -17.83 | -- |
| Mangalam Drugs and Organics Ltd | 3.69bn | -90.72m | 1.54bn | 523.00 | -- | 1.14 | 27.63 | 0.4183 | -5.74 | -5.74 | 232.06 | 85.79 | 1.06 | 1.87 | 9.90 | -- | -2.62 | 3.30 | -4.99 | 5.91 | 33.66 | 29.55 | -2.46 | 2.59 | 0.318 | 0.1951 | 0.4204 | -- | -0.9827 | 10.12 | -814.31 | -- | 4.85 | -- |
| Alpa Laboratories Limited | 1.09bn | 168.28m | 1.57bn | 318.00 | 9.24 | 1.03 | 8.36 | 1.44 | 8.07 | 8.07 | 52.13 | 72.20 | 0.6216 | 5.67 | 2.47 | -- | 9.62 | 7.14 | 11.62 | 8.84 | 31.39 | 33.61 | 15.48 | 10.56 | 5.21 | 16.54 | 0.0334 | -- | 16.98 | 6.87 | 33.33 | 75.36 | 49.57 | -- |
| Vaidya Sane Ayurved Laboratories Ltd | 1.05bn | 36.30m | 1.58bn | 632.00 | 43.40 | 2.88 | 23.68 | 1.51 | 3.46 | 3.46 | 99.55 | 52.12 | 1.74 | 11.90 | 20.17 | 1,654,093.00 | 6.04 | -- | 7.39 | -- | 71.79 | -- | 3.47 | -- | 2.57 | 16.25 | 0.0683 | -- | 32.55 | -- | 49.62 | -- | -- | -- |
| Bal Pharma Ltd | 3.39bn | 73.92m | 1.66bn | -- | 22.29 | 2.39 | 9.46 | 0.4887 | 4.71 | 4.71 | 222.76 | 43.85 | 1.07 | 2.06 | 3.50 | -- | 2.35 | 0.5652 | 6.76 | 1.57 | 43.47 | 43.04 | 2.19 | 0.5638 | 0.7219 | 1.41 | 0.6685 | 79.39 | 11.51 | 8.56 | 187.44 | 14.31 | 5.02 | 3.71 |
| Bafna Pharmaceuticals Ltd | 1.52bn | 73.48m | 2.02bn | 588.00 | 27.48 | 2.50 | 16.38 | 1.33 | 3.11 | 3.11 | 64.50 | 34.17 | 1.10 | 4.12 | 3.52 | -- | 5.30 | 5.45 | 8.32 | 8.23 | 29.88 | 34.17 | 4.82 | 5.97 | 1.20 | 2.67 | 0.2318 | -- | 32.06 | 28.44 | -35.19 | -- | 116.51 | -- |
| Brooks Laboratories Ltd | 794.86m | -195.92m | 2.02bn | 296.00 | -- | 3.09 | -- | 2.55 | -7.71 | -7.71 | 31.27 | 24.99 | 0.7947 | 5.41 | 5.47 | -- | -19.59 | -13.86 | -27.22 | -22.90 | 28.77 | 26.83 | -24.65 | -27.47 | 0.9301 | 0.0657 | 0.0792 | -- | 25.76 | 7.63 | 6.26 | -- | -12.73 | -- |
